# TEC4Home Blood Pressure Randomized Controlled Trial

Study · id `cardio:ct-nct06303206` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06303206](<https://clinicaltrials.gov/study/NCT06303206>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06303206

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 408 participants.

## Technical summary

Registry record NCT06303206. Randomized; no masking; primary purpose treatment. Start 2024-06-01 (anticipated); primary completion 2027-01-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 408 participants (planned count; ClinicalTrials.gov record NCT06303206, source copy `cardio:ctgov-nct06303206-2024-03-12`, retrieved 2026-10-26)
- Planned start: 2024-06-01 (anticipated) (ClinicalTrials.gov record NCT06303206, source copy `cardio:ctgov-nct06303206-2024-03-12`, retrieved 2026-10-26)
- Primary completion: 2027-01-01 (anticipated) (ClinicalTrials.gov record NCT06303206, source copy `cardio:ctgov-nct06303206-2024-03-12`, retrieved 2026-10-26)
- Completion: 2027-01-01 (anticipated) (ClinicalTrials.gov record NCT06303206, source copy `cardio:ctgov-nct06303206-2024-03-12`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06303206-2024-03-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: TEC4Home Blood Pressure Randomized Controlled Trial
- Condition: Hypertension
- Intervention (Device): Home Blood Pressure Telemonitoring (HBPT) + Case Management (CM)
- Lead sponsor: University of British Columbia
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University of British Columbia (`cardio:org-university-of-british-columbia`)

## Provenance

Content hash: 5183b2b32725a2166546e0b72d9a06e321fd36184cbdf509b3c9376eec33a839
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
